HomeComparePOLBF vs YUM

POLBF vs YUM: Dividend Comparison 2026

POLBF yields 3344.48% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POLBF wins by $1284463355857.00M in total portfolio value
10 years
POLBF
POLBF
● Live price
3344.48%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1284463355857.10M
Annual income
$1,213,110,815,498,324,000.00
Full POLBF calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — POLBF vs YUM

📍 POLBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPOLBFYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POLBF + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POLBF pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POLBF
Annual income on $10K today (after 15% tax)
$284,280.94/yr
After 10yr DRIP, annual income (after tax)
$1,031,144,193,173,575,300.00/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, POLBF beats the other by $1,031,144,193,173,540,900.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POLBF + YUM for your $10,000?

POLBF: 50%YUM: 50%
100% YUM50/50100% POLBF
Portfolio after 10yr
$642231677928.61M
Annual income
$606,555,407,749,182,200.00/yr
Blended yield
94.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

POLBF
No analyst data
Altman Z
39.8
Piotroski
1/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POLBF buys
0
YUM buys
0
No recent congressional trades found for POLBF or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPOLBFYUM
Forward yield3344.48%1.86%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$1284463355857.10M$107.9K
Annual income after 10y$1,213,110,815,498,324,000.00$40,443.52
Total dividends collected$1279557275592.29M$81.2K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: POLBF vs YUM ($10,000, DRIP)

YearPOLBF PortfolioPOLBF Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$345,148$334,448.16$10,982$282.06+$334.2KPOLBF
2$11,157,548$10,788,239.94$12,189$438.29+$11.15MPOLBF
3$337,872,856$325,934,279.31$13,731$688.32+$337.86MPOLBF
4$9,585,767,941$9,224,243,985.35$15,789$1,097.12+$9585.75MPOLBF
5$254,836,586,625$244,579,814,927.95$18,679$1,785.08+$254836.57MPOLBF
6$6,349,429,806,239$6,076,754,658,549.98$22,975$2,988.18+$6349429.78MPOLBF
7$148,295,333,941,378$141,501,444,048,701.88$29,784$5,200.49+$148295333.91MPOLBF
8$3,247,334,232,557,481$3,088,658,225,240,206.50$41,408$9,539.16+$3247334232.52MPOLBF
9$66,684,617,157,738,690$63,209,969,528,902,180.00$63,071$18,765.27+$66684617157.68MPOLBF
10$1,284,463,355,857,104,100$1,213,110,815,498,324,000.00$107,930$40,443.52+$1284463355857.00MPOLBF

POLBF vs YUM: Complete Analysis 2026

POLBFStock

Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class intranasally administered RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Full POLBF Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this POLBF vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POLBF vs SCHDPOLBF vs JEPIPOLBF vs OPOLBF vs KOPOLBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.